Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Precision Anti-Cancer Medicines by Oligonucleotide Therapeutics in Clinical Research Targeting Undruggable Proteins and Non-Coding RNAs
Damiano Bartolucci, Andrea Pession, Patrizia Hrelia, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1453-1453
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer
Katia Grillone, Giulio Caridà, Francesco Luciano, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Informed by Cancer Stem Cells of Solid Tumors: Advances in Treatments Targeting Tumor-Promoting Factors and Pathways
Maya R. MacLean, Olivia L. Walker, Raj Pranap Arun, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 4102-4102
Open Access | Times Cited: 15
MYC in cancer: from undruggable target to clinical trials
Jonathan R. Whitfield, Laura Soucek
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 1
MYCN Impact on High-Risk Neuroblastoma: From Diagnosis and Prognosis to Targeted Treatment
Damiano Bartolucci, Luca Montemurro, Salvatore Raieli, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4421-4421
Open Access | Times Cited: 32
Molecular alterations of driver genes in non-small cell lung cancer: from diagnostics to targeted therapy.
Anna Grodzka, Agnieszka Knopik-Skrocka, Katarzyna Kowalska, et al.
PubMed (2023) Vol. 22, pp. 415-432
Closed Access | Times Cited: 19
Exploring the Therapeutic Significance of microRNAs and lncRNAs in Kidney Diseases
Luis Alberto Bravo-Vázquez, Sujay Paul, Miriam Guadalupe Colín-Jurado, et al.
Genes (2024) Vol. 15, Iss. 1, pp. 123-123
Open Access | Times Cited: 8
The Coming Age of Antisense Oligos for the Treatment of Hepatic Ischemia/Reperfusion (IRI) and Other Liver Disorders: Role of Oxidative Stress and Potential Antioxidant Effect
Siyuan Yao, Aanchal Kasargod, Richard Chiu, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 678-678
Open Access | Times Cited: 4
Advancements and challenges in mRNA and ribonucleoprotein-based therapies: From delivery systems to clinical applications
Zohre Eftekhari, Horieh Zohrabi, Akbar Oghalaie, et al.
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 3, pp. 102313-102313
Open Access | Times Cited: 4
Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer
Amalia Kotsifaki, Sousanna Maroulaki, Efthymios Karalexis, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9302-9302
Open Access | Times Cited: 4
Clinical Applications of Antisense Oligonucleotides in Cancer: A Focus on Glioblastoma
A. Khuu, Maïté Verreault, Philippe Colin, et al.
Cells (2024) Vol. 13, Iss. 22, pp. 1869-1869
Open Access | Times Cited: 4
Unravelling key signaling pathways for the therapeutic targeting of non-small cell lung cancer
P. Chavan, Ruchi Pandey, BHEEMANAGOUDA O. PATIL, et al.
European Journal of Pharmacology (2025), pp. 177494-177494
Closed Access
Nanostructures: An Efficient Drug Delivery Platform for Therapy of Multiple Myeloma
Teodora Eliana Petcov, Vadim V. Silberschmidt, Andreea Mădălina Pandele, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100263-100263
Open Access
Targeting Regulatory Noncoding RNAs in Human Cancer: The State of the Art in Clinical Trials
Roberto Piergentili, Stefano Sechi
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 471-471
Open Access
Exploring RNA binding proteins in hepatocellular carcinoma: insights into mechanisms and therapeutic potential
Xing Ren, Wen-Na Yang, Xiuli Yan, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Advancing ovarian cancer management: Role of nucleic acid biomarkers and novel therapeutic approaches
Rutuja Deshmukh, Sharav Desai, Vipul Patel, et al.
Gene Reports (2025), pp. 102241-102241
Closed Access
Preclinical Pharmacokinetics in Tumors and Normal Tissues of the Antigene PNA Oligonucleotide MYCN-Inhibitor BGA002
Anna Lisa Scardovi, Damiano Bartolucci, Luca Montemurro, et al.
Nucleic Acid Therapeutics (2024) Vol. 34, Iss. 4, pp. 173-187
Closed Access | Times Cited: 3
DNA Nanotechnology in Oligonucleotide Drug Delivery Systems: Prospects for Bio-nanorobots in Cancer Treatment
HANIYEH ABDOLLAHZADEH, Tonya L. Peeples, Mohammad Shahcheraghi
(2024)
Open Access | Times Cited: 2
Non-Coding RNAs in Cancer: Mechanistic Insights and Therapeutic Implications
Arjumand John, Nuha Almulla, Noureddine Elboughdiri, et al.
Pathology - Research and Practice (2024) Vol. 266, pp. 155745-155745
Closed Access | Times Cited: 2
The Clinical Potential of L-Oligonucleotides: Challenges and Opportunities
Victoria Shearer, Chen‐Hsu Yu, Xuan Han, et al.
Chemical Science (2024) Vol. 15, Iss. 44, pp. 18239-18258
Open Access | Times Cited: 2
Strategy for Pre-Clinical Development of Active Targeting MicroRNA Oligonucleotide Therapeutics for Unmet Medical Needs
Marc Thibonnier, Sujoy Ghosh
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7126-7126
Open Access | Times Cited: 4
Mechanistic Insights into ASO-RNA Complexation: Advancing Antisense Oligonucleotide Design Strategies
Johanna Hörberg, Antonio Carlesso, Anna Reymer
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 4, pp. 102351-102351
Open Access | Times Cited: 1
New insights of LncRNAs fingerprints in breast cancer progression: Tumorigenesis, drug resistance, and therapeutic opportunities
Bashdar Mahmud Hussen, Diyar Idris Othman, Snur Rasool Abdullah, et al.
International Journal of Biological Macromolecules (2024) Vol. 287, pp. 138589-138589
Open Access | Times Cited: 1
Novel Anticancer Strategies II
Hassan Bousbaa
Pharmaceutics (2023) Vol. 15, Iss. 2, pp. 605-605
Open Access | Times Cited: 1
Advances in RNA therapeutics for modulation of ‘undruggable’ targets
Emily Martinsen, Tasmia Jinnurine, Saranya Subramani, et al.
Progress in molecular biology and translational science (2024), pp. 249-294
Closed Access
Mechanistic Insights into ASO-RNA Complexation: Advancing Antisense Oligonucleotide Design Strategies
Johanna Hörberg, Antonio Carlesso, Anna Reymer
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top